SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-107570
Filing Date
2021-04-06
Accepted
2021-04-06 16:05:53
Documents
6
Period of Report
2021-05-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d318415ddef14a.htm DEF 14A 498446
2 GRAPHIC g318415g11i11.jpg GRAPHIC 48717
3 GRAPHIC g318415g22i22.jpg GRAPHIC 53216
4 GRAPHIC g318415g56f21.jpg GRAPHIC 144427
5 GRAPHIC g318415g66b23.jpg GRAPHIC 25392
6 GRAPHIC g318415g97b74.jpg GRAPHIC 159898
  Complete submission text file 0001193125-21-107570.txt   1078092
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39083 | Film No.: 21809259
SIC: 2836 Biological Products, (No Diagnostic Substances)